z-logo
open-access-imgOpen Access
A CASE STUDY TO EVALUATE THE EFFICACY OF KAL BASTI FOLLOWED BY PANCHATIKTA KSHEER SARPI BASTI IN THE MANAGEMENT OF ASTHIMAJJAGAT VATA WITH SPECIAL REFERENCE TO HLA-B27 (ANKYLOS-ING SPONDYLITIS)
Author(s) -
Seema Bahatkar,
Anita A. Patil,
Kesar N. Kshirsagar
Publication year - 2020
Publication title -
international ayurvedic medical journal
Language(s) - English
Resource type - Journals
ISSN - 2320-5091
DOI - 10.46607/iamj4308082020
Subject(s) - ankylosing spondylitis , medicine , spondylitis , disease , incidence (geometry) , population , physical therapy , traditional medicine , physics , environmental health , optics
Ankylosing spondylitis belongs to group of Rheumatic disease known as spondyloarthropathies which show a strong association with genetic marker HLA-B27. Whereas the incidence of HLA-B27 is less than 1 percent in general population, it is present in more than 85% of patients with ankylosing spondylitis. In-flammatory back pain and stiffness are prominent early in the disease whereas chronic aggressive disease may produce pain and marked axial immobility and deformity. HLA-B27 is the most common findings in Ankylosing Spondylitis. In Ayurveda, no typical nomenclature has been found for the said disease but considering all sing and symptom of the patients, it can be treated as Asthimajjagata vata. No satisfactory treatment is available in modern medicine for this disorder. Various Panchakarma procedures and Ayur-vedic drugs have been proved useful for these manifestations. The patient was considered suffering from Asthimajjagat Vata (HLA-B27) and was treated with Guduchi, Dashamool and Erandmool as Niruha and Bala-guduchyadi Tail as Anuvasana for 16 days as Kal basti followed by Panchatikta ksheera sarpi Basti for 14 days (1 month) was given. Patients condition was assessed for symptoms of Asthimajjagat Vata (HLA-B27 positive). This study shows successfully managed with Ayurvedic treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here